Skip to content
The Kids Research Institute Australia logo

Search

Showing results for "mental health aboriginal"

Have your say

The Children's Diabetes Centre values the importance of community members having a say by giving feedback and guidance on issues important to them.

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)

Pneumococcal disease (PD) remains a major health concern globally. In children, pneumococcal conjugate vaccines (PCVs) provide protection against PD from most vaccine serotypes, but non-vaccine serotypes contribute to residual disease. V114 is a 15-valent PCV containing all 13 serotypes in Prevnar 13™ and public health important serotypes 22F and 33F. This phase 3 study evaluated safety and immunogenicity of mixed PCV13/V114 regimens using a 3 + 1 dosing schedule when changing from PCV13 to V114 at doses 2, 3, or 4. 

Reproduction in females: the role of the early life environment

There is now compelling evidence that long-term health and physiological function are modified by events that occur early in life and involve interactions...

Type 2 Diabetes in Indigenous Australian children

Rates of type 2 diabetes are higher among Indigenous than non-Indigenous Australian children and adolescents.

Dr Jenny Lam

Program Manager

Jailos Lubinda

Senior Research Officer

Karen Lombardi

Senior Research Fellow

Jenny Mountain

Jenny Mountain is a Program Manager in the Neonatal Health team at The Kids Research Institute Australia.

Vu Vuong

Senior Research Officer

The Kids Research Institute Australia shares in new infrastructure funding

The Telethon Kids Institute welcomes the State Government's new $1.2 million funding initiative to support WA's research institutes.